Pharmacogenomic Testing in Current Clinical Practice : Implementation in the Clinical Laboratory
Overview
Part 1. Basic concepts Chapter 1. Issues in Translation of Pharmacogenomics into Clinical Practice. Kiang-Teck J. Yeo, Nikolina Babic, Alan H.B. Wu Chapter 2. Molecular Diagnostic Methods in Pharmacogenomics Nikolina Babic * , Loren J. Joseph, Kiang-Teck J. Yeo Chapter 3. Economics of pharmacogenomic testing in clinical practice Alan H.B. Wu Chapter 4. From Personalized Medicine to Personalized Justice: The Promises of Translational Pharmacogenomics in the Justice System Steven H.Y. Wong, Christopher Happy, Daniel Blinka, Susan Goch, Jeffrey M. Jensen, Joseph M. Donald, Howard Coleman, Saeed A. Jortani, Yolanda Lurie, Cynthia L. Morris-Kukoski, Manuela G. Newman, Paul J. Orsulak, Tara Sander, Michael A. Wagner, Jennifer R. Wynn, Alan H.B. Wu, Kiang-Teck J. Yeo. Part 2. Specific pharmacogenomic targets: Chemotherapeutics Chapter 5. Irinotecan R. Stephanie Huang, Federico Innocenti and Mark J. Ratain Chapter 6. Pharmacogenomics of tamoxifen Christine LH Snozek, Alicia Algeciras-Schimnich, Matthew P Goetz, Loralie J Langman Chapter 7. Thiopurines Terreia S. Jones, Mary V. Relling Part 3. Specific pharmacogenomic targets: Cardiovascular drugs Chapter 8. The Pharmacogenetics of Vitamin K Antagonist Anticoagulation Drugs Charles Eby Chapter 9. Clopidogrel and Salicylates Janice Y Chyou, Marc S Sabatine Chapter 10. DNA-Guided Statin Therapy Gualberto Rua o, Richard L. Seip, Jorge Duconge Chapter 11. The statin response gene: Kif6 ....................... H. Robert Superko, Tom White, James Forrester, Spencer King III. Part 4. Drugs that cause delayed hypersensitivity Chapter 12. Abacavir Elizabeth J. Phillips, Simon A. Mallal Chapter 13. Allopurinol Pei Chen, Shuen-Iu Hung, Shih-Yang Chen, Yuan-Tsong Chen Chapter 14. Carbamazepine and its structurally-related antiepiletics Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen Part 5........ Miscellaneous drugs Chapter 15. Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury Hong-Kee Lee, Lionel D. Lewis Chapter 16. Immunosuppressants Pharmacogenomics Ping Wang Steven H.Y. Wong, Christopher Happy, Daniel Blinka, Susan Goch, Jeffrey M. Jensen, Joseph M. Donald, Howard Coleman, Saeed A. Jortani, Yolanda Lurie, Cynthia L. Morris-Kukoski, Manuela G. Newman, Paul J. Orsulak, Tara Sander, Michael A. Wagner, Jennifer R. Wynn, Alan H.B. Wu, Kiang-Teck J. Yeo. Part 2. Specific pharmacogenomic targets: Chemotherapeutics Chapter 5. Irinotecan R. Stephanie Huang, Federico Innocenti and Mark J. Ratain Chapter 6. Pharmacogenomics of tamoxifen Christine LH Snozek, Alicia Algeciras-Schimnich, Matthew P Goetz, Loralie J Langman Chapter 7. Thiopurines Terreia S. Jones, Mary V. Relling Part 3. Specific pharmacogenomic targets: Cardiovascular drugs Chapter 8. The Pharmacogenetics of Vitamin K Antagonist Anticoagulation Drugs Charles Eby Chapter 9. Clopidogrel and Salicylates Janice Y Chyou, Marc S Sabatine Chapter 10. DNA-Guided Statin Therapy Gualberto Rua o, Richard L. Seip, Jorge Duconge Chapter 11. The statin response gene: Kif6 ..............
This item is Non-Returnable
Customers Also Bought
Details
- ISBN-13: 9781617797262
- ISBN-10: 161779726X
- Publisher: Humana
- Publish Date: April 2013
- Dimensions: 9 x 6.2 x 0.9 inches
- Shipping Weight: 0.9 pounds
- Page Count: 272
Related Categories
